Clinical Trial

Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study

Study acronym: urinary
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2024 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Overactive bladder is a prevalent urological disorder marked by symptoms such as urinary urgency, increased frequency of urination, and nighttime urination (nocturia). Neurotrophins, including nerve growth factor and brain-derived neurotrophic factor, play crucial roles in the development and function of neurons. Recent research has suggested a possible connection between these neurotrophins and OAB. This study sought to explore the relationship between urinary levels of NGF and BDNF and the presence of OAB.
Trial Details
NCT Number NCT06563193
Lead Sponsor Erzincan Binali Yildirim Universitesi
Conditions Overactive Bladder
Enrollment 44 participants
Start Date 2024-08-15
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-20